RSS

option agreement

Q BioMed, a biomedical acceleration and development company, has signed an exclusive option agreement with Washington University in St Louis for a novel companion biomarker for monitoring glaucoma. more

News

Visterra and Vir Biotechnology have entered into a research collaboration, exclusive licence and option agreement for the development and commercialisation of select programmes for infectious diseases. more

News